Endomedix has financed its operations through a combination of sources: sale of common stock in a seed round to accredited investors; a series of SBIR grants issued from National Institutes of Health; and consulting services provided to a third party firm.


Common stock sales: $1.1M

SBIR grants: $2.8M

Consulting services: $0.3M

Total: $4.2M